Confidence:
The Alcon Advantage
IOL Options for Every Patient
Confidence: The Alcon Advantage
IOL Options for Every Patient
Clareon® PanOptix® IOL
PanOptix® delivers an exceptional high-quality visual experience from far to near, with 99% patient satisfaction and over 2.2 million implants worldwide.11-15
Clareon® Monofocal IOL and Clareon® Toric IOL
Our most advanced lens design that delivers pristine visual outcomes.8-10
AcrySof IQ Vivity® IOL
The first and only presbyopia-correcting IOL with wavefront-
shaping technology.1-4
AcrySof® IQ PanOptix® IOL
Patients can now enjoy excellent vision at every meaningful distance.5,6
AcrySof® IQ Monofocal IOL
and AcrySof® IQ Toric IOL
The trusted IOLs that give you confidence.7
Alcon Experience Academy
For relevant training content from industry thought leaders
References:
1. AcrySof IQ Vivity® Extended Vision IOL Directions for Use.
2. Alcon Data on File. US Patent 9968440 B2. 15 May 2018.
3. Alcon Data on File. TDOC-0055575. 09 Apr 2019.
4. Alcon Data on File. TDOC-0055576. 09 Apr 2019.
5. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.
6. Clareon® PanOptix® IOL Directions for Use.
7. Market Scope. 2020 IOL Market Report – Mid-Year Update.
8. Clareon® IOL Directions for use.
9. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45(10):1490-1497.
10. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687.
11. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.
12. Zhu et al. Rate of Complete Spectacle Independence with a Trifocal IOL (PanOptix): A Systematic Literature Review and Meta-Analysis. Presentation at 2022 ASCRS; April 2022; Washington, D.C
13. Market Scope 2022 IOL Market Report.
14. Alcon Data on File, 2022. [REF-18881].
15. Clareon® PanOptix® Trifocal IOL Directions for Use.
Please refer to relevant products DFU or Operator’s manuals for complete list of indications, contraindications and warnings. Please visit ifu.alcon.com for important product information.